Amino Acid Substitutions within the Leucine Zipper Domain of the Murine Coronavirus Spike Protein Cause Defects in Oligomerization and the Ability To Induce Cell-to-Cell Fusion

ABSTRACT The murine coronavirus spike (S) protein contains a leucine zipper domain which is highly conserved among coronaviruses. To assess the role of this leucine zipper domain in S-induced cell-to-cell fusion, the six heptadic leucine and isoleucine residues were replaced with alanine by site-directed mutagenesis. The mutant S proteins were analyzed for cell-to-cell membrane fusion activity as well as for progress through the glycoprotein maturation process, including intracellular glycosylation, oligomerization, and cell surface expression. Single-alanine-substitution mutations had minimal, if any, effects on S-induced cell-to-cell fusion. Significant reduction in fusion activity was observed, however, when two of the four middle heptadic leucine or isoleucine residues were replaced with alanine. Double alanine substitutions that involved either of the two end heptadic leucine residues did not significantly affect fusion. All double-substitution mutant S proteins displayed levels of endoglycosidase H resistance and cell surface expression similar to those of the wild-type S. However, fusion-defective double-alanine-substitution mutants exhibited defects in S oligomerization. These results indicate that the leucine zipper domain plays a role in S-induced cell-to-cell fusion and that the ability of S to induce fusion may be dependent on the oligomeric structure of S.

[1]  R. Fernández-Muñoz,et al.  Measles Virus Fusion Protein Is Palmitoylated on Transmembrane-Intracytoplasmic Cysteine Residues Which Participate in Cell Fusion , 1998, Journal of Virology.

[2]  S. Weiss,et al.  Roles in Cell-to-Cell Fusion of Two Conserved Hydrophobic Regions in the Murine Coronavirus Spike Protein , 1998, Virology.

[3]  D. Z. Cleverley,et al.  The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. K. Young,et al.  The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion. , 1998, Virology.

[5]  R. Center,et al.  Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence , 1997, Journal of virology.

[6]  W. Spaan,et al.  Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein , 1997, Journal of virology.

[7]  A. Kingsman,et al.  The "putative" leucine zipper region of murine leukemia virus transmembrane protein (P15e) is essential for viral infectivity. , 1996, Virology.

[8]  T. Matthews,et al.  Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41 , 1996, Journal of virology.

[9]  P. Earl,et al.  The ectodomain of HIV‐1 env subunit gp41 forms a soluble, alpha‐helical, rod‐like oligomer in the absence of gp120 and the N‐terminal fusion peptide. , 1996, The EMBO journal.

[10]  W. Spaan,et al.  Mutational Analysis of the Murine Coronavirus Spike Protein: Effect on Cell-to-Cell Fusion , 1995, Virology.

[11]  F. Taguchi The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding , 1995, Journal of virology.

[12]  T. Morrison,et al.  Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein , 1995, Journal of virology.

[13]  R. Compans,et al.  Oligomerization of the hydrophobic heptad repeat of gp41 , 1995, Journal of virology.

[14]  B. Kemp,et al.  Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure , 1995, Journal of virology.

[15]  T. Oas,et al.  Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Broder,et al.  Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation , 1994, Journal of virology.

[17]  J. Lee,et al.  Construction of a dimeric repressor: dissection of subunit interfaces in Lac repressor. , 1994, Biochemistry.

[18]  R. Lamb Paramyxovirus fusion: a hypothesis for changes. , 1993, Virology.

[19]  C. N. Lee,et al.  Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein , 1993, Journal of virology.

[20]  R. Lamb,et al.  Folding and assembly of viral membrane proteins. , 1993, Virology.

[21]  E. Hunter,et al.  Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity , 1992, Journal of virology.

[22]  R. Buckland,et al.  A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. , 1992, The Journal of general virology.

[23]  B. Matthews,et al.  Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Dieffenbach,et al.  Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV , 1991, Journal of virology.

[25]  P. D'arco,et al.  Ionicity in silica , 1991, Nature.

[26]  B. Matthews,et al.  Toward a simplification of the protein folding problem: a stabilizing polyalanine alpha-helix engineered in T4 lysozyme. , 1991, Biochemistry.

[27]  C. Pringle,et al.  Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. , 1990, The Journal of general virology.

[28]  W. DeGrado,et al.  A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. , 1990, Science.

[29]  N R Kallenbach,et al.  Side chain contributions to the stability of alpha-helical structure in peptides. , 1990, Science.

[30]  B. Delmas,et al.  Assembly of coronavirus spike protein into trimers and its role in epitope expression , 1990, Journal of virology.

[31]  E. Delwart,et al.  Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat. , 1990, AIDS research and human retroviruses.

[32]  H. Vennema,et al.  Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly , 1990, Journal of virology.

[33]  H. Vennema,et al.  Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice , 1989, Virology.

[34]  J. Visvader,et al.  Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins. , 1989, Genes & development.

[35]  F. Wild,et al.  Leucine zipper motif extends , 1989, Nature.

[36]  P. S. Kim,et al.  Evidence that the leucine zipper is a coiled coil. , 1989, Science.

[37]  T. Kouzarides,et al.  The role of the leucine zipper in the fos–jun interaction , 1988, Nature.

[38]  Marian C. Horzinek,et al.  Coronaviruses: structure and genome expression. , 1988, The Journal of general virology.

[39]  S. McKnight,et al.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.

[40]  Marian C. Horzinek,et al.  Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site , 1987, Virology.

[41]  J. Lenstra,et al.  Evidence for a coiled-coil structure in the spike proteins of coronaviruses☆ , 1987, Journal of Molecular Biology.

[42]  B. Moss,et al.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Cavanagh,et al.  Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. , 1986, The Journal of general virology.

[44]  K. Holmes,et al.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments , 1985, Journal of virology.

[45]  K. Holmes,et al.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion , 1985, Journal of virology.

[46]  H. Klenk,et al.  Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. , 1982, The EMBO journal.

[47]  D. Cavanagh The Coronavirus Surface Glycoprotein , 1995 .

[48]  P. Britton Coronavirus motif , 1991, Nature.

[49]  H. Vennema,et al.  Biosynthesis and function of the coronavirus spike protein. , 1990, Advances in experimental medicine and biology.

[50]  H De Loof,et al.  Amphipathic helix motif: Classes and properties , 1990, Proteins.

[51]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[52]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.